U
GABY Inc. GABLF
OTC PK
Recommendation
--
Prev Close
$0.00145
Volume
--
Avg Vol (90D)
0
Market Cap
$1.08M
Dividend & Yield
--
52-Week Range
$0.0015 - $0.0015
P/E (TTM)
--
EPS (TTM)
-$0.0445
My Lists My Alerts
Rating
Reward
U
Unrated
Risk
U
Unrated
Rating Factors
Growth Index
Unrated
Efficiency Index
Unrated
Solvency Index
Unrated
Total Return Index
Unrated
Volatility Index
Unrated
Dividend Index
Unrated
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$20.73M
EBITDA (TTM)
-$191.60K
EBIT (TTM)
-$1.51M
Net Income (TTM)
-$32.07M
Balance Sheet
Total Assets (Q)
$22.43M
Total Debt (Q)
$30.72M
Total Liabilities (Q)
$47.14M
Book Value Per Share (Q)
-$0.0337
Cash Flow
Cash from Operations (TTM)
$1.64M
Cash from Investing (TTM)
-$91.80K
Cash from Financing (TTM)
-$2.27M
Net Change in Cash (TTM)
-$599.10K
Filings
Filing Date
Tuesday, May 30, 2023
Period Date
Friday, March 31, 2023
Next Filing
(est)
Price History
Loading...
Beta
0.10
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Aug 20, 2024 - $0.0015
52-week High
Aug 20, 2024 - $0.0015
Valuation
Market Cap
$1.08M - Nano Cap
Enterprise Value
$29.98M
Price/Sales (TTM)
0.05
Price/Book (Q)
-0.04
Dividends and Shares
Shares Outstanding
730.74M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.gabyinc.com
Phone Number
800-674-2239
Address
200, 209-8th Avenue SW
Calgary, AB T2P 1B8
Country
Canada
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
GABY Inc., together with its subsidiaries, produces, markets, sells, and retails cannabis-related consumer packaged goods in the United States. The company packages and markets various cannabis... more
Weiss Ratings